This advanced biomarker panel is designed to support the clinical evaluation of Chronic Inflammatory Response Syndrome (CiRS) and other chronic inflammatory conditions. Utilizing ELISA-based detection, it includes plasma markers such as TGF-beta 1, VEGF, C4a, Amsh, and C3a desArg Fragment, as well as serum markers MMP-9, Leptin, and Osmolality. Together, these analytes provide a comprehensive view of immune system activation, vascular and tissue response, and metabolic regulation, offering valuable insight for diagnostic and therapeutic decision-making.

Biomarkers